AIDS Research and Human Retroviruses was the very first AIDS publication in the field over 30 years ago, and today it is still the critical resource advancing research in retroviruses, including AIDS. The Journal provides the broadest coverage from molecular biology to clinical studies and outcomes ...
AIDS RESEARCH AND HUMAN RETROVIRUSES影响因子，是几区 学术期刊《AIDS RESEARCH AND HUMAN RETROVIRUSES》是30多年前该领域的第一份艾滋病出版物，今天它仍然是推进逆转录病毒（包括艾滋病）研究的关键资源。该杂志提供了从分子生物学到临床研究和结果研究的最广泛的报道，重点关注预防科学、新疗法和免疫恢复方法的发展...
《Aids Research And Human Retroviruses》(《艾滋病研究和人类逆转录病毒》)是一本由Mary Ann Liebert Inc.出版的医学-病毒学学术刊物,主要刊载医学-病毒学相关领域研究成果与实践,旨在打造一种学术水平高、可读性强、具有全球影响力的学术期刊。本刊已入选SCIE来源期刊。该刊创刊于1987年,出版周期Monthly。2023年发布...
AIDS RESEARCH AND HUMAN RETROVIRUSES AIDS RES HUM RETROV 最新影响因子:1.723 期刊ISSN:0889-2229 CiteScore:1.67 出版周期:Monthly 是否OA:YES 出版年份:1987 期刊官方网址:http://www.liebertpub.com/overview/aids-research-and-human-retroviruses/2/ 自引率:13.30% 研究方向:医学-病毒学 出版地区:UNITED ...
影响因子:1.5 年发文量:111 出版商:Mary Ann Liebert Inc. 平均审稿速度: 一般,3-6周 期刊发表咨询作者投稿咨询 期刊简介中科院分区JCR分区CiteScore其它数据发文统计投稿提示 Aids Research And Human Retroviruses期刊简介 AIDS Research and Human Retroviruses was the very first AIDS publication in the field ove...
Aids Research And Human Retroviruses AIDS RES HUM RETROV ISSN:0889-2229 E-ISSN:1931-8405 投稿咨询学术服务 基本信息 BASIC INFORMATION 审稿时间:一般,3-6周 出版周期:Monthly 出版国家或地区:UNITED STATES 创刊:1987 影响因子:1.5 是否预警:否 语言:English...
《AIDS RESEARCH AND HUMAN RETROVIRUSES》 期刊名缩写:AIDS RES HUM RETROV 22年影响因子:1.723 issn:0889-2229 eIssn:1931-8405 类别:医学生物农林科学 学科与分区:传染病(INFECTIOUS DISEASES) - SCIE(Q4)病毒学(VIROLOGY) - SCIE(Q4)免疫学(IMMUNOLOGY) - SCIE(Q4)...
期刊全称 AIDS Research and Human Retroviruses 3.3 CiteScore 620 过去四年文献总数 2050 过去四年引用总数 70 % 被引用比率 Print ISSN 0889-2229 出版社 Mary Ann Liebert Scopus链接 https://www.scopus.com/sourceid/21771 开放出版 Open Access 否...
AIDS Research and Human Retroviruseswas the very first AIDS publication in the field 40 years ago, and today it is still the critical resource advancing research in retroviruses, including AIDS. The Journal provides the broadest coverage from molecular biology to clinical studies and outcomes research...